SLGL
Sol Gel Technologies Ltd
NASDAQ: SLGL · HEALTHCARE · BIOTECHNOLOGY
$74.04
+3.70% today
Updated 2026-04-30
Market cap
$230.14M
P/E ratio
—
P/S ratio
11.87x
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$4 – $98
Volume
0.0M
Sol Gel Technologies Ltd (SLGL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.83M | $-8.04M | $-18.50M | $-24.09M | $-23.47M | $-22.50M | $-25.24M | $-7.69M | $-9.48M | $-17.73M | $-13.89M | $322000.00 |
| Capital expenditures | $268000.00 | $291000.00 | $385000.00 | $1.93M | $1.05M | $597000.00 | $449000.00 | $143000.00 | $171000.00 | $134000.00 | $2000.00 | $47000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $1.13M | $952000.00 | $3.97M | $4.65M | $2.55M | $1.22M | $687000.00 | $1.53M | $1.86M | $786000.00 | $82000.00 |
| Free cash flow | $-5.10M | $-8.34M | $-18.88M | $-26.01M | $-24.52M | $-23.10M | $-25.69M | $-7.83M | $-9.65M | $-17.86M | $-13.89M | $275000.00 |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |